From precursor to reprogrammed cells: evolution of cardiomyoplasty
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Myocardial infarction is underoxygenation-driven limited necrosis of heart tissues which results in elimination of ca. 0.5 to 1 billion spontaneously contracting cardiomyocytes (CM). Since the ability of human heart to regenerate is limited, efforts have been undertaken to increase the number of cardiomyocytes in post-infarction myocardium. Theoretically, such proposals might involve transplantation of 1) skeletal myoblasts and cardiomyocytes, or 2) progenitor/stem cells, theoretically capable of differentiating into cardiomyocytes, or 3) pluripotent cells such as embryonal stem cells (ESC) and induced pluripotent stem cells (iPSC) differentiating into cardiomyocytes. The efforts to increase CM could also involve 4) in situ reprogramming of fibroblasts into active cardiomyocyte-like cells, or 5) stimulating in situ proliferation of cardiomyocytes using pharmacological agents. Only three proposals merit closer scrutiny (2, 4 and 5). However, preclinical and clinical data have demonstrated weak ability of progenitor cells to differentiate (proposal 2). Nevertheless, transplanted cell-induced paracrine effects accompanying such therapy do improve functioning of the damaged heart muscle. The proposals that would permit the number of CM to be increased include in situ reprogramming of fibroblasts into active cardiomyocytes (proposal 4), as well as in situ stimulation of quiescent cardiomyocytes’ proliferation (proposal 5). It appears that an optimized therapeutic solution (increasing left ventricular ejection fraction and decreasing the post-infarct scar) might combine agents stimulating paracrine effects and reprogramming of fibroblasts.
Authors and Affiliations
Stanisław Szala, Sybilla Matuszczak, Justyna Czapla, Ewa Wiśniewska
Keywords
Related Articles
- EP ID EP67287
- DOI -
- Views 152
- Downloads 0
Anestezjologia w sieci cytokin
The role of ghrelin in the organism
Ghrelin was discovered in 1999 as an endogenous ligand of the growth hormone secretagogue receptor (GHS-R). About 60–70% of ghrelin in the blood is released from oxyntic cells (X/A-like cells) of the stomach body and f...
Microevolution of BCG substrains
Tuberculosis was, and still is, one of the main causes of morbidity and mortality in the world. Thus it still remains a public health priority. Nonetheless, without a newly developed vaccine, it is rather unlikely to be...
Badanie potencjału przeciwwolnorodnikowego różnych rodzajów herbat oraz wyciągów uzyskanych z tych herbat za pomocą jednostki aktywności przeciwwolnorodnikowej (TAU)
Wprowadzenie: Herbata zielona, czarna i pu-erh mają, w porównaniu do innych surowców roślinnych, silne właściwości przeciwwolnorodnikowe. W pracy zbadano15 różnych herbat należących do trzech typów, zielonych, czarnych...
Biologiczne skutki stresu oksydacyjnego wywołanego działaniem pestycydów
Pestycydy są powszechnie stosowane do ochrony roślin, produktów roślinnych, a także są wykorzystywane w wielu gałęziach przemysłu. Zaliczane są do związków szkodliwych. Mimo istniejących rygorystycznych kontroli ich st...